Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial.

BACKGROUND Replacing SFAs with vegetable PUFAs has cardiometabolic benefits, but the effects on liver fat are unknown. Increased dietary n-6 PUFAs have, however, also been proposed to promote inflammation-a yet unproven theory. OBJECTIVE We investigated the effects of PUFAs on liver fat, systemic inflammation, and metabolic disorders. DESIGN We randomly assigned 67 abdominally obese subjects (15% had type 2 diabetes) to a 10-wk isocaloric diet high in vegetable n-6 PUFA (PUFA diet) or SFA mainly from butter (SFA diet), without altering the macronutrient intake. Liver fat was assessed by MRI and magnetic resonance proton (1H) spectroscopy (MRS). Proprotein convertase subtilisin/kexin type-9 (PCSK9, a hepatic LDL-receptor regulator), inflammation, and adipose tissue expression of inflammatory and lipogenic genes were determined. RESULTS A total of 61 subjects completed the study. Body weight modestly increased but was not different between groups. Liver fat was lower during the PUFA diet than during the SFA diet [between-group difference in relative change from baseline; 16% (MRI; P < 0.001), 34% (MRS; P = 0.02)]. PCSK9 (P = 0.001), TNF receptor-2 (P < 0.01), and IL-1 receptor antagonist (P = 0.02) concentrations were lower during the PUFA diet, whereas insulin (P = 0.06) tended to be higher during the SFA diet. In compliant subjects (defined as change in serum linoleic acid), insulin, total/HDL-cholesterol ratio, LDL cholesterol, and triglycerides were lower during the PUFA diet than during the SFA diet (P < 0.05). Adipose tissue gene expression was unchanged. CONCLUSIONS Compared with SFA intake, n-6 PUFAs reduce liver fat and modestly improve metabolic status, without weight loss. A high n-6 PUFA intake does not cause any signs of inflammation or oxidative stress. Downregulation of PCSK9 could be a novel mechanism behind the cholesterol-lowering effects of PUFAs. This trial was registered at clinicaltrials.gov as NCT01038102.

[1]  L. Berglund,et al.  Replacing dairy fat with rapeseed oil causes rapid improvement of hyperlipidaemia: a randomized controlled study , 2011, Journal of internal medicine.

[2]  J. Hsu,et al.  Time-dependent effects of safflower oil to improve glycemia, inflammation and blood lipids in obese, post-menopausal women with type 2 diabetes: a randomized, double-masked, crossover study. , 2011, Clinical nutrition.

[3]  Kjeld Hermansen,et al.  The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010? , 2011, The American journal of clinical nutrition.

[4]  Myung‐Sook Choi,et al.  Differential effect of corn oil-based low trans structured fat on the plasma and hepatic lipid profile in an atherogenic mouse model: comparison to hydrogenated trans fat , 2011, Lipids in Health and Disease.

[5]  M. Eriksson,et al.  Circulating Proprotein Convertase Subtilisin Kexin Type 9 Has a Diurnal Rhythm Synchronous With Cholesterol Synthesis and Is Reduced by Fasting in Humans , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[6]  U. Risérus,et al.  Role of hepatic desaturases in obesity-related metabolic disorders , 2010, Current opinion in clinical nutrition and metabolic care.

[7]  H. Yki-Järvinen.  Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data , 2010, Current opinion in clinical nutrition and metabolic care.

[8]  D. Reboussin,et al.  Effect of a 12-Month Intensive Lifestyle Intervention on Hepatic Steatosis in Adults With Type 2 Diabetes , 2010, Diabetes Care.

[9]  H. Yki-Järvinen.  Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes , 2010, Digestive Diseases.

[10]  J. Árnlöv,et al.  Serum fatty acid composition and insulin resistance are independently associated with liver fat markers in elderly men. , 2010, Diabetes research and clinical practice.

[11]  D. Mozaffarian,et al.  Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2010, PLoS medicine.

[12]  M. Jokela,et al.  Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes , 2010, Diabetes.

[13]  E. Schleicher,et al.  Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. , 2009, Clinical chemistry.

[14]  K. Brismar,et al.  Cocoa Butter and Safflower Oil Elicit Different Effects on Hepatic Gene Expression and Lipid Metabolism in Rats , 2009, Lipids.

[15]  B. S. Mohammed,et al.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity , 2009, Proceedings of the National Academy of Sciences.

[16]  J. Hsu,et al.  Comparison of dietary conjugated linoleic acid with safflower oil on body composition in obese postmenopausal women with type 2 diabetes mellitus. , 2009, The American journal of clinical nutrition.

[17]  M. Orešič,et al.  Hepatic Stearoyl-CoA Desaturase (SCD)-1 Activity and Diacylglycerol but Not Ceramide Concentrations Are Increased in the Nonalcoholic Human Fatty Liver , 2009, Diabetes.

[18]  Walter C Willett,et al.  Dietary fats and prevention of type 2 diabetes. , 2009, Progress in lipid research.

[19]  F. Schick,et al.  High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease , 2008, Gut.

[20]  K. Fritsche.  Too much linoleic acid promotes inflammation-doesn't it? , 2008, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  S. Piro,et al.  Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. , 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[22]  J. Manson,et al.  Low-carbohydrate-diet score and risk of type 2 diabetes in women. , 2008, The American journal of clinical nutrition.

[23]  O. Receveur,et al.  Could the Quality of Dietary Fat, and Not Just Its Quantity, Be Related to Risk of Obesity? , 2008, Obesity.

[24]  Pascal G. P. Martin,et al.  Novel aspects of PPARα‐mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study , 2007, Hepatology.

[25]  B. Monia,et al.  Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. , 2006, The Journal of clinical investigation.

[26]  J. Schölmerich,et al.  Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. , 2006, Journal of molecular endocrinology.

[27]  P. Legrand,et al.  Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. , 2006, Progress in lipid research.

[28]  Jonathan C. Cohen,et al.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. , 2006, The New England journal of medicine.

[29]  A. Häkkinen,et al.  Dietary fat content modifies liver fat in overweight nondiabetic subjects. , 2005, The Journal of clinical endocrinology and metabolism.

[30]  Christoph Handschin,et al.  Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP , 2005, Cell.

[31]  M. Leuze,et al.  The human fatty acid synthase gene and de novo lipogenesis are coordinately regulated in human adipose tissue. , 2004, The Journal of nutrition.

[32]  Nader Rifai,et al.  Inflammatory markers and risk of developing type 2 diabetes in women. , 2004, Diabetes.

[33]  J. Breslow,et al.  Novel putative SREBP and LXR target genes identified by microarray analysis in liver of cholesterol-fed mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains one supplemental table. Published, JLR Papers in Press, August 1, 2003. DOI 10.1194/jlr.M300203-JLR200 , 2003, Journal of Lipid Research.

[34]  Jay D. Horton,et al.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Weissenbach,et al.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia , 2003, Nature Genetics.

[36]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[37]  A. Häkkinen,et al.  Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. , 2003, Diabetes.

[38]  F. Sacks,et al.  Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. , 2002, The American journal of medicine.

[39]  A. Brownlie,et al.  Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200189-JLR200 , 2002, Journal of Lipid Research.

[40]  B. Fielding,et al.  Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity , 2002, Diabetologia.

[41]  B. M. Rasmussen,et al.  Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study , 2001, Diabetologia.

[42]  S. Basu.  Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[43]  S. Basu.  Radioimmunoassay of 8-iso-prostaglandin F2alpha: an index for oxidative injury via free radical catalysed lipid peroxidation. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[44]  R. Mensink,et al.  Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. , 1997, American journal of epidemiology.

[45]  P. Kris-Etherton,et al.  Reducing saturated fat intake is associated with increased levels of LDL receptors on mononuclear cells in healthy men and women. , 1997, Journal of lipid research.

[46]  J. Girard,et al.  Regulation of lipogenic enzyme gene expression by nutrients and hormones , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  R. Mensink,et al.  Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[48]  R. Heine,et al.  Linoleic-acid-enriched diet: long-term effects on serum lipoprotein and apolipoprotein concentrations and insulin sensitivity in noninsulin-dependent diabetic patients. , 1989, The American journal of clinical nutrition.

[49]  H. Kempen,et al.  Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. , 1988, Journal of lipid research.

[50]  B. Vessby,et al.  Platelet fatty acid composition in relation to fatty acid composition in plasma and to serum lipoprotein lipids in healthy subjects with special reference to the linoleic acid pathway. , 1985, Clinical science.